Leflunomide [
HWA 486 or RS-34821, 5-methyl-N-(4trifluoromethylphenyl)-4-isoxazole carboximide] is an immunosuppressive agent effective in the treatment of
rheumatoid arthritis. Dihydroortate
dehydrogenase (DHODH, EC 1.3.3.1) immobilization on the nanotubes was carried out and biochemical characterization of free and
immobilized enzyme was determined. In comparison with free enzyme, the immobilized DHODH showed improved stability and reusability for investigation of inhibition pattern of drugs such as
leflunomide. The experimental data showed that, DHODH was inhibited by the active metabolite of
leflunomide (RS-61980) with a Ki and KI of 0.82 and 0.06 mM, respectively. Results exhibited mixed-type inhibition kinetics towards
dihydroorotate as a substrate in the free and
immobilized enzyme. Furthermore, the behavior of anticancer drug
leflunomide adsorbed on the external surface of zigzag single walled (6,0)
carbon and
boron nitride nanotubes (SWCNT and SWBNNT) was studied by means of DFT calculations at the B3LYP/6-31G(*) level of theory. The larger adsorption energies and charges transfer showed that the adsorption of
leflunomide onto SWBNNT is more stable than that the adsorption of
leflunomide onto SWCNT. Frontier molecular orbitals (HOMO and LUMO) suggest that adsorption of
leflunomide onto SWBNNT behave as charge transfer compounds with
leflunomide as an electron donor and SWBNNT as an electron acceptor. Thus, nanotubes (NTs) have been proposed and actively explored as multipurpose innovative carriers for drug delivery and diagnostic application. The AIM theory has been also applied to analyze the properties of the bond critical points: their electron densities and their laplacians. Also, the natural bond orbital (NBO) calculations were performed to derive natural atomic orbital occupancies, and partial charges of the interacting atoms in the equilibrium tube-molecule distance.